Stellar Pharmaceuticals Inc. (TSX VENTURE: SLX)(OTCBB: SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced the signing of a Licensing Agreement with BIO-TECHNIC ROMANIA SRL for NeoVisc® in Romania. The population base for Romania is in excess of 21 million people. Revenues will commence once in-country regulatory approval is received.
